THC Signs MOU to Acquire Interest in Cannabinoid Medical Clinics
13 Maio 2014 - 3:29PM
Marketwired
THC Signs MOU to Acquire Interest in Cannabinoid Medical Clinics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 13, 2014) -
Thelon Capital Ltd. (the "Company")
(TSX-VENTURE:THC)(FRANKFURT:TFHC) is pleased to announce that it
has entered into a MOU to purchase 100% of a Private Federal
Corporation, 8824479 Canada Inc.(Holdco.) Holdco has the exclusive
option to purchase a 30% interest in The Cannabinoid Medical
Clinic. THC will advance $200,000 to Holdco to secure a 45-day due
diligence period to enter into a definitive agreement.
Scott Walters, President of Thelon stated, "We feel this is a
great opportunity to work with physicians who want to develop a
good standard of care for the patients who are using medical
marijuana. The research and education aspect of the clinic really
stood out as an opportunity to set the standard for future growth.
The Cannabinoid Clinics will be available to patients only by
referral from their General Practitioners."
The Cannabinoid Medical Clinic will be the first in a series of
clinics in Ontario to provide services to patients under the
Marihuana for Medical Purposes Regulations (MMPR). The clinical
mission is to facilitate safe access to medical marihuana to
patients who may receive a therapeutic benefit.
This agreement is subject to Board, shareholder and TSX.V
approval.
The Company continues to evaluate new projects, including, but
not limited to, opportunities in agriculture, finance, and
resources. At this time, no transactions are in place, nor is there
any assurance that a new project will be concluded in the
future."
ON BEHALF OF THE BOARD OF DIRECTORS
Scott Walters, President & Chief Executive Officer
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy of
accuracy of this release.
This news release contains forward-looking statements that
involve risks and uncertainties. Forward-looking statements or
information are based on current expectations, estimates and
projections that involve a number of risks and uncertainties which
could cause actual results to differ materially from those
anticipated by the Company. The forward-looking statements or
information contained in this news release are made as of the date
hereof and the Company does not undertake any obligation to update
publicly or revise any forward-looking statements or information,
whether as a result of new information, future events or otherwise,
unless so required by applicable securities laws.
Thelon Capital Ltd.Scott WaltersPresident & Chief Executive
Officer(604) 682-1643(604) 682-1666www.theloncapital.com
Thelon Capital Ltd. (TSXV:THC)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Thelon Capital Ltd. (TSXV:THC)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
